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Abstract
Population-based HIV surveillance is crucial to inform understanding of the HIV pandemic
and evaluate HIV interventions, but little is known about longitudinal participation patterns in
such settings. We investigated the dynamics of longitudinal participation patterns in a high
HIV prevalence surveillance setting in rural South Africa between 2003 and 2012, taking
into account demographic dynamics. At any given survey round, 22,708 to 30,495 persons
were eligible. Although the yearly participation rates were relatively modest (26% to 46%),
cumulative rates increased substantially with multiple recruitment opportunities: 68% of eli-
gible persons participated at least once, 48% at least twice and 31% at least three times
after five survey rounds. We identified two types of study fatigue: at the individual level, con-
tact and consent rates decreased with multiple recruitment opportunities and, at the popula-
tion level, these rates also decreased over calendar time, independently of multiple
recruitment opportunities. Using sequence analysis and hierarchical clustering, we identi-
fied three broad individual participation profiles: consenters (20%), switchers (43%) and re-
fusers (37%). Men were over represented among refusers, women among consenters, and
temporary non-residents among switchers. The specific subgroup of persons who were sys-
temically not contacted or refusers constitutes a challenge for population-based surveil-
lance and interventions.
Introduction
Over the past two decades, population-based longitudinal HIV surveillance [1–4] has proven
to be of great value in helping to understand the dynamics of the HIV pandemic and to evalu-
ate the impact of HIV programs in developing countries [5–7]. HIV incidence has commonly
been inferred from observed prevalence changes over time in subsequent cross-sectional
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surveys (such as Demographic and Health Surveys) using some mortality assumptions [8,9].
However, with access to antiretroviral treatment expanding rapidly, such approaches are be-
coming increasingly unreliable due the rapidly decreasing HIV-specific mortality [6,10–12].
Population-based longitudinal HIV surveillance therefore remains the gold standard for mea-
suring HIV incidence and monitoring incidence changes over time [13].
However, little is known about the underlying dynamics of participation patterns (i.e. par-
ticipation outcomes in a sequence of survey rounds) in HIV surveillance, which are embedded
within demographic dynamics (mortality, aging in, migration) and how these participation dy-
namics affect HIV prevalence and incidence estimates. Previous work has mainly focused on
factors associated with participation in single, or at best two cross-sectional surveys [14–18], or
on cumulative rates in HIV negative people to estimate incidence [19]. Participation in a longi-
tudinal context is a dynamic process (i.e. acceptability could change over time), which interacts
with underlying demographic changes.
Furthermore, universal repeat HIV testing and immediate antiretroviral treatment (“test
and treat”) strategies constitute one of the major current research questions in the HIV field
[20], with four on-going large-scale cluster randomized trials [21–25] in Southern Africa.
These trials face similar operational challenges in terms of contact and participation at popula-
tion level [26].Understanding participation patterns in the context of a longitudinal HIV sur-
veillance could be informative for these trials and any population-based intervention.
One of the main challenges facing population-based HIV surveillance is to ensure adequate
statistical representation of the general population, or, at the very least, adequate statistical re-
presentation of the general population within strata of key variables used to re-weight the sur-
veyed population to reflect the general population. A high participation rate is required for
accurate estimation of HIV prevalence, as participation is likely to depend on HIV status
[27,28] which leads to biased estimates [29–31]. Further, because of the longitudinal nature of
HIV surveillance, repeat participation and attrition rates are crucial to both ensure comparabil-
ity of prevalence estimates over time and to measure HIV incidence, because incidence estima-
tion requires at least two measurement points in time [32].
The main purpose of our study is thus to measure the evolution of annual participation
rates, to identify potential study ‘fatigue’ over time, to investigate longitudinal participation
patterns and to assess their potential impact on estimates of HIV prevalence and incidence in a
high HIV prevalence surveillance setting in a rural area in KwaZulu-Natal, South Africa, where
annual HIV surveys have been conducted since 2003 among the adult resident population.
Material and Methods
Study setting
The Africa Centre for Health and Population Studies has hosted a socio-demographic house-
hold surveillance in a rural sub-district of uMkhanyakude in northern KwaZulu-Natal (South
Africa) since 2000. The surveillance area is 438 km2 in size and includes a population of ap-
proximately 90 000 isiZulu-speaking people [1]. The study area is characterized by high adult
HIV prevalence (24% in adults aged 15 years and older in 2011) and high levels of poverty and
unemployment (in 2010, 67% of adults over the age of 18 were unemployed). At any point in
time, about one-third of the population under demographic surveillance does not physically re-
side in the surveillance area, although they are considered to be household members (member-
ship is defined by household head). Demographic events and socio-economic data are
collected on a regular basis from a key household informant.
Starting in 2003, a nested HIV surveillance was conducted among resident adults, who were
invited to respond to a health and sexual behaviour questionnaire and to provide a small blood
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sample which was tested for HIV [14]. For each survey round, teams of two trained fieldwor-
kers visited each eligible individual in their households. If a person was absent, the field work-
ers made up to four repeat visits to the same household. Except for the first HIV surveillance
round, which took place over 18 months starting in 2003, all subsequent rounds were done on
annual basis. For this analysis, we used data collected between 2003 and 2012, corresponding
to a total of nine survey rounds.
Eligibility to participate in HIV surveillance
All adults residing in the area and who were able to provide informed written consent were eli-
gible to participate in HIV surveillance. From 2003 to 2006, eligibility was restricted to women
aged 15–49 years and men aged 15–54. From 2007 onwards, all persons aged 15 years and
older were eligible.
The population of eligible resident participants changes substantially on a yearly basis. Thus
from 2004 onwards, at the beginning of each calendar year, a list of all resident persons eligible
to participate in HIV surveillance was generated from information available in the demograph-
ic database. During fieldwork operations, some persons became ineligible “a posteriori”, be-
cause the information of death, out-migration or sickness was not available at the time the
eligibility list was generated or because their situation changed. These persons were treated as
ineligible for the purpose of our analysis.
Ethic Statement
Informed written consent was obtained from all adult eligible persons aged 15 year or older for
participation in the surveillance and to provide a small blood sample for HIV analysis for re-
search purposes. As permitted by the regulatory framework governing research in South Africa
at the time of the study [33], we obtained written informed consent from adolescents aged 15–
17 years themselves. Ethical approval for HIV surveillance (reference numbers E029/03, E122/
06 for the extension beyond age 50 years and BF233/09 for the combined ages) was obtained
from the Biomedical Research Ethics Committee (BREC) of the University of KwaZulu-Natal,
and renewed on an annual basis. The BREC was aware that some of the surveillance partici-
pants were minors and approved the age range of participation and the specific consent proce-
dure for minors.
Data Availability Statement
Data are available from the INDEPTH data repository (doi: 10.7796/INDEPTH.AC.HIV.
Participation.2003.2012.v1, http://www.indepth-ishare.org/index.php/catalog/53/).
Annual participation rate
In any given survey round, we defined the HIV surveillance acceptance rate as the proportion
consenting to provide a blood sample for HIV testing among persons who were contacted; and
the effective HIV surveillance coverage as the proportion consenting to provide a blood sample
among all eligible persons.
Statistical analysis
The use of sequence analysis [34,35] in social sciences has significantly increased during the
last two decades [36,37]. In this approach, outcomes are not studied independently of each
other but rather as a sequence. For our study, we considered participation as a sequence of suc-
cessive participation outcomes, of which there were three types: (i) the person was not
Participation Dynamics in HIV Surveillance
PLOS ONE | DOI:10.1371/journal.pone.0123345 April 13, 2015 3 / 16
contacted; (ii) the person was contacted but refused to participate; (iii) the person was con-
tacted and consented to participate, i.e. the person accepted to provide a finger prick blood
sample for HIV testing.
The participation sequence of a person, as illustrated on Fig 1, is the series of participation
outcomes for each surveillance round during which she/he was eligible for HIV surveillance.
The length of a participation sequence is the total number of times (minimum: 1; maximum: 9)
a person was eligible for HIV surveillance, i.e. the number of participation outcomes for that
person. The length of the participation sequence can vary between persons. For example, due
to temporary outmigration, a participant could become ineligible for one (or more) surveil-
lance round in between two rounds during which she/he was eligible (see example 2 on Fig 1).
The participation sequence length is also influenced by the year in which a person first becomes
eligible, or ceases to be eligible due to outmigration or death. Thus, a person who was 15 years
old in 2010 could only have a maximum participation sequence length of three by the end
2012. The sequence position refers to the position of a given participation outcome within a
specific sequence.
To investigate the concept of ‘study fatigue’, which postulates that persons become less in-
terested and thus less likely to participate repeatedly in a study over time, we used two binomial
logistic regression models to estimate the probability of being contacted vs. not being contacted
(using all participation outcomes, see Fig 1) and the probability of consenting vs. refusing to
participate (among contacts), as a function of sequence position (i.e. the nth time where a per-
son was eligible), while adjusting for sex, age, sequence length, survey round (calendar time),
having temporarily migrating outside the study area and prior observed HIV status.
To investigate patterns of participation over the long term, we focused our analysis on per-
sons with a long participation sequence length, i.e. persons who were eligible at least seven
times. We restricted the sequence analysis to long sequences (of length of 7 to 9) because the
distance metric between two sequences we employed is also influenced by difference in se-
quence length. A hierarchical classification of the entire population would have been unduly
influenced by sequence length rather than participation status dynamics. Dissimilarity between
sequences was calculated using optimal matching techniques before dividing the population
into several groups (participation profiles) using hierarchical classification and describing par-
ticipation sequences classes. We used the Longest Common Subsequence (LCS) distance to
compute distances between sequences (see example on Fig 1). LCS distance is a special case of
optimal matching distance [38]. A dendrogram was computed using the Wald algorithm. We
used the higher relative loss of inertia criterion to determine the optimal number of partitions
(see function HCPC in FactoMineR package [39,40]). We used odds ratio as effect size indica-
tor to describe participation profiles.
Sankey diagrams (flow diagrams in which the thickness of the lines is proportional to the
flow quantity) were used to represent the dynamic of the eligible population over time and the
participation dynamic by sequence position of each participation profile.
All statistical analyses were performed using R 3.0.1 [41]. Sankey diagrams were constructed
using an adapted version of Mike Bostock’s script for D3.js (http://bost.ocks.org/mike/sankey/).
Sequence analysis was performed using the TraMineR package [42]. Color palettes were chosen
from http://colorbrewer2.org/ to be colorblind safe. All figures were edited with Inkscape 0.48.
Results
Population dynamics
Fig 2 shows the longitudinal eligibility dynamics of the population of individuals under HIV
surveillance. Whereas cumulatively 60,954 persons were eligible at least once over the decade
Participation Dynamics in HIV Surveillance
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Fig 1. Examples of the methodological approach used to compute sequences and Longest Common Subsequence distance.
doi:10.1371/journal.pone.0123345.g001
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(S1 Table), only between 22,708 and 30,495 persons were eligible during any single survey
round. Between 2,839 and 5,898 adults definitively exited (deaths, out-migration, before 2007
becoming age-ineligible) and between 1,515 and 8,792 adults entered into (ageing into, in-mi-
gration) the HIV surveillance in single survey rounds. The number of entries was higher from
2007 onwards because the upper-age eligibility criterion (which was 50 for women and 55 for
men prior to 2007) was removed. More than a quarter of all eligible persons (28.8%) were tem-
porarily ineligible during at least one round, due to temporary out-migration. Of the 26,589
persons that were eligible in the first round in 2003/2004, only 11,088 (41.7%) remained eligi-
ble in round 9 in 2012. Taken together, these data suggest a fairly rapid turnover of the under-
lying population under HIV surveillance in this setting due to demographic processes
including migration, ageing, and death.
Overall, the HIV surveillance acceptance rate remained relatively stable at 32–41% after the
first survey round (Fig 3). The effective HIV surveillance coverage decreased from 46% in
2003/2004 to 26% in 2012, reflecting changes in contact rates. Between 2003/2004 and 2005,
the proportion not contacted decreased from 21% to 5%, due to logistic improvements in the
way the survey was conducted by establishing a list of eligible persons at the beginning of the
survey round (see materials and methods). However, between 2005 and 2012, the proportion
not re-contacted increased progressively from 5% to 23%, indicating potential ‘study fatigue’.
Although the effective HIV surveillance participation rate in any single survey round might
appear to be low, it is important to consider multiple recruitment opportunities in a longitudi-
nal setting. Thus, cumulatively after five rounds, 68% of all eligible persons participated at least
once, 48% at least twice and 31% at least three times (Fig 4). Due to the fact that a minimum of
one blood sample is required for estimating HIV prevalence and two blood samples for HIV
Fig 2. Eligibility flow chart in a Sankey diagram (flow diagram in which the thickness of the lines is proportional to the flow quantity) by survey
round.Different colours represent the year in which persons first became eligible for HIV surveillance. The numbers in the grey bars represent the number of
persons eligible for HIV surveillance during a given survey round. The numbers below the grey bars represent the persons who enter or exit the HIV
surveillance eligible population because of death, in- and out-migration or ageing into the open cohort.Annual participation rates and cumulative rates.
doi:10.1371/journal.pone.0123345.g002
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Fig 3. Crude annual participation rates (including the effective HIV surveillance coverage) and HIV
surveillance acceptance rates by survey round.
doi:10.1371/journal.pone.0123345.g003
Fig 4. Proportion of persons having consented to provide a blood sample at least once, twice or three
times as a function of sequence position.
doi:10.1371/journal.pone.0123345.g004
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incidence, only two-thirds of the sample was used for prevalence and half of the sample for
incidence estimation.
Study ‘fatigue’
The concept of study ‘fatigue’ postulates that persons become less likely to participate repeated-
ly in a study over time. Overall, we found that men and persons aged 20–49 years were less like-
ly to be contacted or to consent to participate if contacted than women (p<0.001) and persons
of other ages (Table 1). Persons who had never consented to provide a blood sample were less
likely to consent in subsequent rounds (p<0.0001). Having a prior positive HIV test was signif-
icantly associated with refusal (p<0.0001), but was not associated with non-contact
(p = 0.8965). Sequence length was negatively associated with contact (adjusted Odds Ratio
[aOR] length of 9 vs. length of 1: 2.955, p<0.0001) and, to a lesser extent, with refusal (aOR
length of 9 vs. length of 1: 1.142, p<0.0001). Persons having temporarily migrated outside the
surveillance area were less likely to be contacted (aOR = 0.636, p<0.0001) but not to refuse to
participate (aOR = 0.986, p = 0.2094). The sequence position was negatively associated with
contact and with consent, which could indicate a certain degree of study fatigue (aOR 9th out-
come vs.1st outcome is 0.302, p<0.0001 for contact and 0.178, p<0.0001 for consent). While
contact improved in the first survey rounds, calendar time was found to be negatively associat-
ed with contact in later rounds (aOR 2012 vs. 2008: 0.206, p<0.0001). For consent, adjusted
odds ratios decreased between 2003/2004 and 2008, followed by an improvement in 2010 and
2011 (aOR vs. 2008: 1.508 and 1.472 respectively, p<0.0001).
Participation profiles
In order to identify participation profiles, we conducted a cluster analysis of persons with long
participation sequences, with a length of 7–9 survey rounds. While persons with long (7–9
rounds) participation sequences represented 19% of the 60,954 persons who were ever eligible,
they represented 33–47% of eligible persons during any given survey round (S1 Fig) and 38.3%
of all participation outcomes. Hierarchal clustering analysis suggests three major classes of par-
ticipation profiles (S2 and S3 Figs) corresponding to three broad participation types. The par-
ticipation flowchart of each profile is represented in Fig 5 and characteristics described in
Table 2. For convenience, and according to their participation flowchart (Fig 5), we decided to
name these participation profiles as “consenters” (20% of long sequences), “switchers” (43%)
and “refusers” (37%).
Consenters generally had refusal rates below 20% at any sequence position (except for the
8th and the 9th outcome where it increased to 23% and 34%, respectively). Consenters who re-
fused to participate in any round were more likely to consent to participate in the subsequent
round (Fig 5). On average, consenters participated more than 6 times and all consenters partic-
ipated at least three times (Table 2). On the other hand, refusers participated 0.5 times on aver-
age, 35% participated at least once and 10% at least twice. Switchers displayed important
patterns of switching between consent and refusal (Fig 5). The acceptance rate among switchers
decreased progressively from 67% for first outcome to 22% for the 9th outcome. Almost all of
the switchers (99.9%) were tested at least once and 84% at least twice, the average number of
HIV tests being 2.9 (Table 2).
Men were over-represented among refusers, women among consenters, and temporarily in-
eligible persons among switchers (Table 2). Over-represented age-groups for each participation
profile were 15–29 years old for switchers, 20–49 for refusers and 15–19 and the 40 years and
older for consenters. Observed HIV incidence was higher among switchers than consenters
(2.8% versus 2.1%, OR = 1.353). Most importantly, observed HIV prevalence by sequence
Participation Dynamics in HIV Surveillance
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Table 1. Factors associated with contact and consent from two binomial logistic regression model.
Contacted vs. Not contacted Consented vs. Refused (among contacted)
aOR p aOR p
Sequence position
1st 1 1
2nd 0.910 0.0028 ** 0.411 0.0000 ***
3rd 0.704 0.0000 *** 0.290 0.0000 ***
4th 0.654 0.0000 *** 0.249 0.0000 ***
5th 0.591 0.0000 *** 0.240 0.0000 ***
6th 0.518 0.0000 *** 0.217 0.0000 ***
7th 0.450 0.0000 *** 0.199 0.0000 ***
8th 0.392 0.0000 *** 0.196 0.0000 ***
9th 0.302 0.0000 *** 0.178 0.0000 ***
Sex of participant
female 1 1
male 0.576 0.0000 *** 0.722 0.0000 ***
Age of participant
15–19 1.589 0.0000 *** 1.326 0.0000 ***
20–29 1 0 1
30–39 0.801 0.0000 *** 0.908 0.0000 ***
40–49 0.853 0.0000 *** 1.023 0.1531 -
50 or more 1.490 0.0000 *** 1.425 0.0000 ***
Sequence length
1 1 1
2 0.981 0.5763 - 1.043 0.1335 -
3 1.448 0.0000 *** 1.087 0.0018 **
4 1.655 0.0000 *** 1.087 0.0030 **
5 1.959 0.0000 *** 1.107 0.0000 ***
6 2.503 0.0000 *** 1.164 0.0000 ***
7 2.473 0.0000 *** 1.121 0.0001 ***
8 2.784 0.0000 *** 1.154 0.0000 ***
9 2.955 0.0000 *** 1.142 0.0000 ***
Survey round
2003/2004 0.186 0.0000 *** 2.650 0.0000 ***
2005 0.879 0.0049 ** 1.332 0.0000 ***
2006 1.390 0.0000 *** 1.283 0.0000 ***
2007 0.564 0.0000 *** 1.029 0.1596 -
2008 1 1
2009 0.759 0.0000 *** 1.024 0.2438 -
2010 0.339 0.0000 *** 1.508 0.0000 ***
2011 0.305 0.0000 *** 1.472 0.0000 ***
2012 0.206 0.0000 *** 1.077 0.0013 **
Last observed HIV status (in previous rounds)
negative 1 1
positive 1.003 0.8965 - 0.919 0.0000 ***
unknown 0.770 0.0000 *** 0.196 0.0000 ***
Having temporarily migrated outside the surveillance area
no 1 1
(Continued)
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position was higher among refusers than among consenters (22.1% vs. 15.5%, OR = 1.553 for
the first outcome; 42.9% vs. 24.5%, OR = 2.313 for the 9th outcome) or among switchers (22.1%
vs. 18.5%, OR = 1.254 for the first outcome; 42.9% vs. 31.6%, OR = 1.624 for the 9th outcome).
Observed HIV incidence among refusers (2.3%) was estimated only on the 9.8% who pro-
vided a sample for testing twice and is thus a limited indicator for this group (not representa-
tive and sample size too small, there is no statistically significant difference between observed
incidence among refusers and incidence among consenters, p = 0.7643, or switchers,
p = 0.3418, using Fisher test). Another proxy of HIV incidence could be the increase of HIV
prevalence. Between the first and the 9th outcomes, observed HIV prevalence increased by
9.0% for consenters, 13.1% for switchers and by 20.8% for refusers. It should be noted however
that prevalence could also increase in case of improved coverage of HIV treatment and, conse-
quently, of reduction in mortality due to HIV.
Discussion
Due to substantial levels of mortality [6], in- and out-migration [43,44], ageing into the cohort
and the fact that migration is associated with HIV and death [45,46], the target population of
HIV surveillance in this setting changes considerably on a yearly basis. For example overall
21% of the target population was eligible only once and 29% were temporarily ineligible.
One of the main criticisms addressed at population-based HIV surveillance is the low yearly
participation rates [47]. Our analysis shows that the proportion of persons who were effectively
covered by HIV surveillance increased substantially with cumulative recruitment opportuni-
ties. Approximately two-thirds consented at least once and approximately half at least twice to
participate within five years of becoming eligible.
Refusal could constitute an important source of bias for prevalence and incidence estima-
tion. We showed that refusal was associated with sex and age, and we estimated HIV preva-
lence to be substantially higher among refusers [48,49]. Of concern is the finding that HIV
incidence is likely to be higher among refusers. Our results are consistent with other analyses
showing that HIV-infected persons were significantly less likely than HIV-uninfected persons
to consent to participate during a single survey round [17]. Persons knowing that they are HIV
positive could be reluctant to participate in the surveillance as the Africa Centre is known to
collaborate with the Department of Health in the local HIV treatment and care programme
[50], but also because they may think that their status is already known and thus another test
would be futile [18]. Consequently, HIV prevalence estimates from cross-sectional surveys
would under-estimate the true HIV prevalence in the population, because persons enrolled in
pre-antiretroviral treatment (ART) care or on ART care would less likely participate in HIV
surveillance. This challenge could be addressed by asking persons who do not consent to give
Table 1. (Continued)
Contacted vs. Not contacted Consented vs. Refused (among contacted)
aOR p aOR p
yes 0.636 0.0000 *** 0.986 0.2094 -
247,040 observations for model 1 (contacted vs. not contacted). 220,096 observations for model 2 (consented vs. refused). aOR: adjusted Odds Ratio.
*** p  0.001,
** 0.001< p  0.01,
* 0.01 < p  0.05,—p > 0.05.
doi:10.1371/journal.pone.0123345.t001
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blood to report their HIV status or whether they are on pre-ART care or in care, although this
could pose ethical challenges [51].
We were able to detect two types of study ‘fatigue’. The first was clearly related to individu-
al-level ‘fatigue’, i.e. the more frequently persons were asked to participate, the less likely they
were to repeatedly consent. Secondly, we also detected a wider ‘surveillance system fatigue’, i.e.
a tendency over time for participation rates to decrease in later rounds compared to earlier
Fig 5. Participation flow chart by sequence position in a Sankey diagram (flow diagram in which the thickness of the lines is proportional to the
flow quantity) of the three participation profiles (consenters, switchers, refusers) identified by the cluster analysis in persons with long
participation sequence (7–9 rounds). This flowchart represents the flows between participation outcomes from one sequence position to the next one.
doi:10.1371/journal.pone.0123345.g005
Table 2. Characteristics of three participation profiles (consenters, switchers, refusers) identified by the cluster analysis in persons with long par-
ticipation sequence (7–9 rounds).
Consenters Switchers Refusers All
n 2,401 5,076 4,321 11,798
% 20.4 43.0 36.6 100.0
Sex
female (%) 75.0 62.0 56.7 62.7
male (%) 25.0 38.0 43.3 37.3
Age at ﬁrst participation
15–19 y. (%) 24.6 27.3 17.2 23.0
20–29 y. (%) 19.3 24.2 23.3 22.9
30–39 y. (%) 19.4 21.0 28.3 23.4
40–49 y. (%) 30.6 22.5 26.1 25.5
50+ y. (%) 6.1 5.0 5.0 5.2
median (years) 33 29 33 31
HIV tests
mean 6.2 2.9 0.5 2.7
At least one (%) 100.0 99.9 35.0 76.2
At least two (%) 100.0 84.1 9.8 60.1
At least three (%) 100.0 58.2 1.3 45.9
Observed HIV prevalence by sequence position (%)
1st 15.5 18.5 22.1 17.7
2nd 16.7 22.6 24.7 20.2
3rd 17.9 24.2 28.6 21.5
4th 20.9 26.6 28.6 23.7
5th 23.9 29.6 28.7 26.4
6th 26.3 31.6 30.3 28.7
7th 27.7 36.8 38.8 32.5
8th 27.2 35.4 40.3 31.7
9th 24.5 31.6 42.9 29.1
Observed HIV seroconversions
number of conversions 275 448 24 747
person-years of observation 13,345 16,064 1,068 30,477
observed HIV incidence (‰) 20.6 27.9 22.5 24.5
Having temporarily migrated outside the surveillance area
no 61.9 55.5 60.5 58.6
yes 38.1 44.5 39.5 41.4
doi:10.1371/journal.pone.0123345.t002
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rounds. This could be due to a changing local social perception of HIV surveillance, of persons
not being convinced of the utility of HIV surveillance or even of a fatigue of the surveillance
system including field workers. The latter could explain the observed increase of non-contacts
in later survey rounds. However, qualitative work would be required to explore these
hypotheses.
From an HIV intervention perspective, our results could be used to help assess the likely
population impact of a test and treat strategy currently evaluated through large trials. One of
the main challenges of test and treat trials is to repeatedly reach a high proportion of the total
population. Even if the setting of a trial is different from a surveillance setting, our study shows
that refusal and non-contacts could be a major issue. More than a fifth (23.4%, see Fig 3) of the
total population was never tested after nine survey rounds. A similar result has been shown in
the context of home-based testing in Malawi where 11% of individuals remained unreached
after two home-based testing campaigns [52]. Preliminary results (after three home-based sur-
vey rounds) from the ANRS 12249 Treatment as Prevention trial, currently on-going in the
same district as our HIV surveillance, showed a contact rate per survey round of 78% and a
HIV ascertainment rate per survey round of 82% [26]. Although these rates are better than the
ones observed in our study, our results highlight the risk that a study fatigue may occur
over time.
To our knowledge, this is the first time that Sankey diagrams and this type of sequence anal-
ysis has been applied to longitudinal HIV epidemiology. These methods allow a detailed de-
scription of the complex participation dynamics in an open longitudinal cohort and deserve
wider attention in similar other settings.
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